TY  - GEN
AU  - Nomura,Hisashi
AU  - Takahashi,Hayato
AU  - Suzuki,Satsuki
AU  - Kurihara,Yuichi
AU  - Chubachi,Shotaro
AU  - Kawada,Ichiro
AU  - Yasuda,Hiroyuki
AU  - Betsuyaku,Tomoko
AU  - Amagai,Masayuki
AU  - Funakoshi,Takeru
TI  - Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy
SN  - 1346-8138
PY  - 2018///0409
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antineoplastic Agents, Immunological
KW  - Biopsy
KW  - CTLA-4 Antigen
KW  - antagonists & inhibitors
KW  - Chemotherapy, Adjuvant
KW  - adverse effects
KW  - Drug Eruptions
KW  - diagnosis
KW  - Drug Resistance
KW  - Erythema Multiforme
KW  - chemically induced
KW  - Fever
KW  - Glucocorticoids
KW  - pharmacology
KW  - Humans
KW  - Indoles
KW  - Ipilimumab
KW  - Lung Diseases, Interstitial
KW  - drug therapy
KW  - Lymphatic Metastasis
KW  - Male
KW  - Melanoma
KW  - genetics
KW  - Mutation
KW  - Neoplasm Recurrence, Local
KW  - pathology
KW  - Nivolumab
KW  - Parotid Neoplasms
KW  - Programmed Cell Death 1 Receptor
KW  - Proto-Oncogene Proteins B-raf
KW  - Pulse Therapy, Drug
KW  - Skin Neoplasms
KW  - Sulfonamides
KW  - Tomography, X-Ray Computed
KW  - Trimethoprim, Sulfamethoxazole Drug Combination
KW  - Vemurafenib
KW  - Withholding Treatment
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1111/1346-8138.13810
ER  -